Dexiang Gao

9PUBLICATIONS
99CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2026
A Phase II Trial Using Grape Seed Extract for Prostate Cancer Patients With Nonmetastatic Prostate-Specific Antigen Progression After Local Therapy.

|Oct 23, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts.

J Jason Morton, Stephan A Ramos, Nathaniel Alzofon

|Jul 31, 2025
Respiratory viral infections awaken metastatic breast cancer cells in lungs.

Shi B Chia, Bryan J Johnson, Junxiao Hu

|May 16, 2025
A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.

Breelyn A Wilky, Katherine A Julian, Alessandra Maleddu

|Jun 30, 2023
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.

Cera Nieto, Bettina Miller, Nathaniel Alzofon

|Jun 26, 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.

Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman

Pageof 2

Frequent Collaborators

2 joint publications

Andrew Nicklawsky

2 joint publications

Antonio Jimeno

2 joint publications

Cera Nieto

2 joint publications

William Robinson